Impact of Isotope Dilution Mass Spectrometry (IDMS) Standardization on Carboplatin Dose and Adverse Events-Reference-Cited by-同舟云学术

Impact of Isotope Dilution Mass Spectrometry (IDMS) Standardization on Carboplatin Dose and Adverse Events

Published:2016-06 Issue:6 Volume:36 Page:617-622
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Lawson Justin¹,Switchenko Jeffrey M.²,McKibbin Trevor¹³,Donald Harvey R.³⁴

Affiliation:

1. Department of Pharmaceutical Services; Emory Healthcare; Atlanta Georgia

2. Biostatistics & Bioinformatics Shared Resource; Rollins School of Public Health; Winship Cancer Institute of Emory University; Atlanta Georgia

3. Department of Hematology and Medical Oncology; School of Medicine, and Winship Cancer Institute; Emory University; Atlanta Georgia

4. Department of Pharmacology; School of Medicine; Emory University; Atlanta Georgia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference18 articles.

1. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin;Go;J Clin Oncol,1999

2. Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II;Calvert;Cancer Chemother Pharmacol,1982

3. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function;Harland;Cancer Res,1984

4. Results of NCI-sponsored phase I trials with carboplatin;Foster;Cancer Treat,1985

5. Carboplatin dosage: prospective evaluation of a simple formula based on renal function;Calvert;J Clin Oncol,1989

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study;Gynecologic Oncology;2023-07

2. Pretreatment Platelet Count and Neutrophil/Lymphocyte Ratio Are Predictive Markers for Carboplatin Plus Pemetrexed Therapy-induced Thrombocytopenia;Anticancer Research;2021-11

3. Burden of chronic kidney disease in the general population and high-risk groups in South Asia: A systematic review and meta-analysis;PLOS ONE;2021-10-14

4. Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker;Cancer Chemotherapy and Pharmacology;2020-09-18

5. Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review;Journal of Oncology Pharmacy Practice;2018-10-18